BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30777653)

  • 1. Genetic variants in nicotinic receptors and smoking cessation in Parkinson's disease.
    Chuang YH; Paul KC; Sinsheimer JS; Bronstein JM; Bordelon YM; Ritz B
    Parkinsonism Relat Disord; 2019 May; 62():57-61. PubMed ID: 30777653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exploratory study on the CHRNA3-CHRNA5-CHRNB4 cluster, smoking, and Parkinson's disease.
    Gao J; Xu H; Weinberg C; Huang X; Park Y; Hollenbeck A; Blair A; Schatzkin A; Burch L; Chen H
    Neurodegener Dis; 2011; 8(5):296-9. PubMed ID: 21228559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: gene and smoking status interaction.
    Greenbaum L; Rigbi A; Lipshtat N; Cilia R; Tesei S; Asselta R; Djaldetti R; Goldwurm S; Lerer B
    Parkinsonism Relat Disord; 2013 Jan; 19(1):72-6. PubMed ID: 22884254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.
    Tyndale RF; Zhu AZ; George TP; Cinciripini P; Hawk LW; Schnoll RA; Swan GE; Benowitz NL; Heitjan DF; Lerman C;
    PLoS One; 2015; 10(5):e0128109. PubMed ID: 26010901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic acetylcholine gene cluster CHRNA5-A3-B4 variants influence smoking status in a Bangladeshi population.
    Chaity NI; Sultana TN; Hasan MM; Shrabonee II; Nahid NA; Islam MS; Apu MNH
    Pharmacol Rep; 2021 Apr; 73(2):574-582. PubMed ID: 33675519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
    Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL
    BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHRNA5-A3-B4 and DRD2 Genes and Smoking Cessation Throughout Adulthood: A Longitudinal Study of Women.
    Jones SK; Alberg AJ; Wallace K; Froeliger B; Carpenter MJ; Wolf BJ
    Nicotine Tob Res; 2023 May; 25(6):1164-1173. PubMed ID: 36794842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism.
    Wen L; Jiang K; Yuan W; Cui W; Li MD
    Mol Neurobiol; 2016 Jan; 53(1):472-484. PubMed ID: 25471942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort.
    Bousman CA; Rivard C; Haese JD; Ambrosone C; Hyland A
    Am J Med Genet B Neuropsychiatr Genet; 2012 Mar; 159B(2):227-35. PubMed ID: 22223462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis.
    Chen LS; Baker T; Hung RJ; Horton A; Culverhouse R; Hartz S; Saccone N; Cheng I; Deng B; Han Y; Hansen HM; Horsman J; Kim C; Rosenberger A; Aben KK; Andrew AS; Chang SC; Saum KU; Dienemann H; Hatsukami DK; Johnson EO; Pande M; Wrensch MR; McLaughlin J; Skaug V; van der Heijden EH; Wampfler J; Wenzlaff A; Woll P; Zienolddiny S; Bickeböller H; Brenner H; Duell EJ; Haugen A; Brüske I; Kiemeney LA; Lazarus P; Le Marchand L; Liu G; Mayordomo J; Risch A; Schwartz AG; Teare MD; Wu X; Wiencke JK; Yang P; Zhang ZF; Spitz MR; Amos CI; Bierut LJ
    EBioMedicine; 2016 Sep; 11():219-226. PubMed ID: 27543155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease.
    Ritz B; Lee PC; Lassen CF; Arah OA
    Neurology; 2014 Oct; 83(16):1396-402. PubMed ID: 25217056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.
    Zhu AZ; Zhou Q; Cox LS; David SP; Ahluwalia JS; Benowitz NL; Tyndale RF
    Clin Pharmacol Ther; 2014 Aug; 96(2):256-65. PubMed ID: 24733007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking.
    Bar-Shira A; Gana-Weisz M; Gan-Or Z; Giladi E; Giladi N; Orr-Urtreger A
    Neurobiol Aging; 2014 Sep; 35(9):2179.e1-6. PubMed ID: 24731518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quitting smoking: an early non-motor feature of Parkinson's disease?
    Moccia M; Erro R; Picillo M; Vassallo E; Vitale C; Longo K; Amboni M; Santangelo G; Palladino R; Nardone A; Triassi M; Barone P; Pellecchia MT
    Parkinsonism Relat Disord; 2015 Mar; 21(3):216-20. PubMed ID: 25547948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers.
    Halldén S; Sjögren M; Hedblad B; Engström G; Hamrefors V; Manjer J; Melander O
    J Intern Med; 2016 Apr; 279(4):388-98. PubMed ID: 26689306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme.
    Bray MJ; Chen LS; Fox L; Hancock DB; Culverhouse RC; Hartz SM; Johnson EO; Liu M; McKay JD; Saccone NL; Hokanson JE; Vrieze SI; Tyndale RF; Baker TB; Bierut LJ
    Genet Epidemiol; 2020 Oct; 44(7):748-758. PubMed ID: 32803792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population.
    Pérez-Morales R; González-Zamora A; González-Delgado MF; Calleros Rincón EY; Olivas Calderón EH; Martínez-Ramírez OC; Rubio J
    Ann Hum Genet; 2018 Nov; 82(6):415-424. PubMed ID: 29993116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction.
    Chen LS; Bach RG; Lenzini PA; Spertus JA; Bierut LJ; Cresci S
    Nicotine Tob Res; 2014 Sep; 16(9):1224-31. PubMed ID: 24727484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence.
    Lee SH; Ahn WY; Seweryn M; Sadee W
    BMC Genomics; 2018 Nov; 19(1):826. PubMed ID: 30453884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between CHRNA3 and CHRNA5 Nicotine Receptor Subunit Gene Variants and Nicotine Dependence in an Isolated Populationof Kashubians in Poland.
    Kita-Milczarska K; Sieminska A; Jassem E
    Med Sci Monit; 2016 Apr; 22():1442-50. PubMed ID: 27127891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.